Actinomyces turicensis: a peculiar case of empyema after COVID-19 in a patient with ulcerative colitis
Abstract
Actinomyces species are recognized as common mucosal bacteria in humans and as a newly discovered source of infection. Since its discovery in 1995, the subspecies Actinomyces turicensis has been reported as the causative pathogen of numerous infections. Only two instances of A. turicensis-related empyema, however, have been documented in the literature as of late. We report a unique case of polymicrobial empyema caused by A. turicensis shortly after a COVID-19 without any clear risk factors for anaerobic aspiration, along with a brief review of the literature. Tetracycline was successfully used for the first time to treat A. turicensis empyema, following chest drainage.
References
- Valour F, Sénéchal A, Dupieux C, et al. Actinomycosis: etiology, clinical features, diagnosis, treatment, and management. Infect Drug Resist 2014;7:183-97. DOI: https://doi.org/10.2147/IDR.S39601
- Könönen E, Wade WG. Actinomyces and related organisms in human infections. Clin Microbiol Rev 2015;28:419-42. DOI: https://doi.org/10.1128/CMR.00100-14
- Smego Jr RA, Foglia G. Actinomycosis. Clin Infect Dis 1998;26:1255-61. DOI: https://doi.org/10.1086/516337
- Sabbe LJ, Van De Merwe D, Schouls L, et al. Clinical spectrum of infections due to the newly described Actinomyces species A. turicensis, A. radingae, and A. europaeus. J Clin Microbiol 1999;37:8-13. DOI: https://doi.org/10.1128/JCM.37.1.8-13.1999
- Johnson SW, Billatos E. Polymicrobial empyema: a novel case of Actinomyces turicensis. Respir Med Case Rep 2021;32:101365. DOI: https://doi.org/10.1016/j.rmcr.2021.101365
- Agrafiotis AC, Lardinois I. Pleural empyema caused by Actinomyces turicensis. New Microbes New Infect 2021;41:100892. DOI: https://doi.org/10.1016/j.nmni.2021.100892
- Russo TA. Agents of actinomycosis. In: Principles and practice of infectious disease. 5th edition. Mandell GL (eds.). Philadelphia: Elsevier, Churchill Livingstone; 1995:2645-54.
- Kim SR, Jung LY, Oh IJ, et al. Pulmonary actinomycosis during the first decade of 21st century: cases of 94 patients. BMC Infect Dis 2013;13:216. DOI: https://doi.org/10.1186/1471-2334-13-216
- Mabeza GF, Macfarlane J. Pulmonary actinomyces. Eur Respir J 2003;21:545-51. DOI: https://doi.org/10.1183/09031936.03.00089103
- Hall V, Talbot PR, Stubbs SL, Duerden BI. Identification of clinical isolates of Actinomyces species by amplified 16S ribosomal DNA restriction analysis. J Clin Microbiol. 2001;39:3555-62. DOI: https://doi.org/10.1128/JCM.39.10.3555-3562.2001
- Hoheisel A, Herrmann MJ, Kassi E, et al. Actinomyces meyeri pleural empyema: a case report. IDCases 2021;26:e01278. DOI: https://doi.org/10.1016/j.idcr.2021.e01278
- Cheon JE, Im JG, Kim MY, et al. Thoracic actinomycosis: CT findings. Radiology 1998;209:229-33. DOI: https://doi.org/10.1148/radiology.209.1.9769836
- Smith AJ, Hall V, Thakker B, Gemmell CG. Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents. J Antimicrob Chemother 2005;56:407-9. DOI: https://doi.org/10.1093/jac/dki206
- Steininger C, Willinger B. Resistance patterns in clinical isolates of pathogenic Actinomyces species. J Antimicrob Chemother 2016;71:422-7. DOI: https://doi.org/10.1093/jac/dkv347
- Hooper C, Lee YCG, Maskell N. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010;65:ii4-ii17- DOI: https://doi.org/10.1136/thx.2010.136978
- Freire MP, Oliveira MS, Magri MMC, et al., HCFMUSP COVID-19 Study Group, Levin AS. Frequency and factors associated with hospital readmission after COVID-19 hospitalization: the importance of post-COVID diarrhea. Clinics (Sao Paulo). 2022;77:100061. DOI: https://doi.org/10.1016/j.clinsp.2022.100061
- Guarin G, Lo KB, Bhargav R, et al. Factors associated with hospital readmissions among patients with COVID‐19: a single‐center experience. J Med Virol 2021;93:5582‐7. DOI: https://doi.org/10.1002/jmv.27104
- Romero-Duarte Á, Rivera-Izquierdo M, Guerrero-Fernández de Alba I, et al. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med 2021;19:129. DOI: https://doi.org/10.1186/s12916-021-02003-7
- Topić MB, Desnica B, Vicković N, et al. The polymicrobial Actinomyces naeslundii and Pseudomonas aeruginosa sepsis in a patient with ulcerative colitis 2 months after colonoscopy. Wien Klin Wochenschr 2014;126:130-2. DOI: https://doi.org/10.1007/s00508-013-0471-7
- Cunha F, Sousa DL, Trindade L, Duque V. Disseminated cutaneous Actinomyces bovis infection in an immunocompromised host: case report and review of the literature. BMC Infect Dis 2022;22:310. DOI: https://doi.org/10.1186/s12879-022-07282-w
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2024 the Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.